Mixing-tank model for predicting dissolution rate control or oral absorption.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Pharmacy and Science

• Publication date

  1986-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/JPS.2600750202PMID 3958917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absorption potential: estimating the fraction absorbed for orally administered compounds.

  1985cited by this paper
• Intestinal transit of solid and liquid components of a meal in health

  1984cited by this paper
• Physicochemical model for dose-dependent drug absorption.

  1984cited by this paper
• Intestinal transit of solid and liquid components of a meal in health.

  1984cited by this paper
• Quantitative, mechanistic and physiologically realistic approach to the biopharmaceutical design of oral drug delivery systems

  1983cited by this paper
• Passage of carbohydrate into the colon. Direct measurements in humans.

  1983cited by this paper
• Passage of carbohydrate into the colon. Direct measurements in humans

  1983cited by this paper
• Relationship of motility to flow of contents in the human small intestine.

  1982cited by this paper
• A MATHEMATICAL MODEL OF DRUG ABSORPTION

  1981cited by this paper
• Substituent constants for correlation analysis in chemistry and biology

  1979cited by this paper
• Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.

  1979cited by this paper
• Changes in crystallinity and solubility on comminution of digoxin and observations on spironolactone and oestradiol *

  1976cited by this paper
• Effect of particle size on the bioavailability of digoxin

  1975cited by this paper
• The effect of particle size on the absorption of digoxin

  1974cited by this paper
• Absorption of orally given digoxin preparations.

  1972cited by this paper
• Absorption characteristics of solid dispersed and micronized griseofulvin in man.

  1971cited by this paper
• Parameters affecting absorption of griseofulvin in a human subject using urinary metabolite excretion data.

  1970cited by this paper
• Correlation of dissolution rate and griseofulvin absorption in man.

  1967cited by this paper
• Particle size of commercial griseofulvin with reference to official standards.

  1967cited by this paper
• Drug and tracer kinetics

  1966cited by this paper
• Volume-Flow Relationship During the Transport of Fluid Through the Human Small Intestine

  1965cited by this paper
• Gastrointestinal absorption of griseofulvin. II. Influence of particle size in man.

  1962cited by this paper
• The effect of griseofulvin particle size on blood levels in man.

  1962cited by this paper
• Human pharmacology of griseofulvin: the effect of fat intake on gastrointestinal absorption.

  1961cited by this paper
• THE UNITED STATES PHARMACOPEIA.

  1908cited by this paper
• The British Pharmacopeia.

  1901cited by this paper
• The rate of solution of solid substances in their own solutions

  1897cited by this paper

• Comparison of the z-factor and Polli dissolution rate coefficient for monodisperse powders.

  2025cites this paper
• Transient pH film model for in vitro powder dissolution of weakly acidic drugs into buffer: Consideration of surface acidification and comparison to conventional film model.

  2025cites this paper
• Minimal Physiologically-Based Pharmacokinetic Modeling of Atenolol and Metoprolol Absorption in Malnourished Rats

  2025cites this paper
• Prediction of surfactant-mediated dissolution of poorly soluble drugs from drug powder

  2025cites this paper
• Advances in Modeling Approaches for Oral Drug Delivery: Artificial Intelligence, Physiologically-Based Pharmacokinetics, and First-Principles Models

  2024cites this paper
• Potential of nanostructured lipid carriers in oral delivery of the poorly soluble drugs

  2023cites this paper
• Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS)

  2023cites this paper
• Bioequivalence Dissolution Test Criteria for Formulation Development of High Solubility-Low Permeability Drugs.

  2023cites this paper
• Physiological Dynamics in the Upper Gastrointestinal Tract and the Development of Gastrointestinal Absorption Models for the Immediate-Release Oral Dosage Forms in Healthy Adult Human

  2023cites this paper
• Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series

  2022cites this paper
• The Use of Physiologically Based Pharmacokinetic Analyses—in Biopharmaceutics Applications -Regulatory and Industry Perspectives

  2022cites this paper
• Application of Physiologically Based Absorption and Pharmacokinetic Modeling in the development process of oral modified release generic products.

  2022cites this paper
• Dynamic Transit Models

  2021cites this paper
• Square root law model for the delivery and intestinal absorption of drugs: a case of hydrophilic captopril

  2021cites this paper
• Dissolution and drug release

  2021cites this paper
• Lost in modelling and simulation?

  2021cites this paper
• Lilly Absorption Modeling Platform: A Tool for Early Absorption Assessment.

  2021cites this paper
• Role of Pharmacokinetics and Pharmacokinetic Modeling in Drug Development

  2021cites this paper
• UNCERTAINTY AND POPULATION VARIABILITY

  2021cites this paper
• Jennifer Dressman - 40 years of oral drug absorption.

  2021cites this paper
• Optimization of Amorphization Kinetics during Hot Melt Extrusion by Particle Engineering: An Experimental and Computational Study

  2021cites this paper
• Food Effects on Oral Drug Absorption: Application of Physiologically-Based Pharmacokinetic Modeling as a Predictive Tool

  2020cites this paper
• Evaluation of valsartan biopharmaceutics properties.

  2019cites this paper
• Accounting for inter-correlation between enzyme abundance: a simulation study to assess implications on global sensitivity analysis within physiologically-based pharmacokinetics

  2019cites this paper
• Kinetic investigation of a controlled drug delivery system based on alginate scaffold with embedded voids

  2019cites this paper
• Solubility, Permeability, and Their Interplay

  2018cites this paper
• Optimization Techniques Applications in Biochemical Engineering and Controlled Drug Delivery: Current Practices and Forthcoming Challenges

  2018cites this paper
• ADME Processes in Pharmaceutical Sciences

  2018cites this paper
• In Vitro and In Silico ADME Prediction

  2018cites this paper
• Preformulation Aspects of Insoluble Compounds

  2018cites this paper
• Preparation and characterization of microencapsulated DwPT trivalent vaccine using water soluble chitosan and its in-vitro and in-vivo immunological properties.

  2018cites this paper
• Suitability of in vitro, in silico and in vivo methods to predict intestinal absorption in drug development

  2018cites this paper
• Variance based global sensitivity analysis of physiologically based pharmacokinetic absorption models for BCS I–IV drugs

  2018cites this paper
• The Effects of Temperature and Dissolution Media on Crystallization of Amorphous Drugs and Potential Effects on Predicting Bioavailability

  2018influential citation
• Nanoformulations of Ibuprofen and Soluplus ® for Enhanced Oral Bioavailability . 10 . 1

  2017cites this paper
• Dissolution of Nanoparticle Drug Formulations

  2017cites this paper
• Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models

  2017cites this paper
• Assessment of Bioequivalence of Weak Base Formulations Under Various Dosing Conditions Using Physiologically Based Pharmacokinetic Simulations in Virtual Populations. Case Examples: Ketoconazole and Posaconazole.

  2017cites this paper
• Theoretical Investigation of Dissolution Test Criteria for Waiver of Clinical Bioequivalence Study.

  2016cites this paper
• Oral Drug Absorption

  2016cites this paper
• A modelling framework for bulk particles dissolving in turbulent regime

  2016cites this paper
• Biopharmaceutic classification of drugs revisited.

  2016cites this paper
• Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs

  2015cites this paper
• Analysis of Diffusion-Controlled Dissolution from Polydisperse Collections of Drug Particles with an Assessed Mathematical Model.

  2015influential citation
• Quality control and comparative dissolution profile of Ibuprofen oral suspension

  2015cites this paper
• Rate- and Extent-Limiting Factors of Oral Drug Absorption: Theory and Applications.

  2015cites this paper
• KINETIC MODELING OF RASAGILINE MESYLATE FROM NANOSCALE SOLID LIPID PARTICLES

  2015cites this paper
• Drug Delivery and Release From Polymeric Nanomaterials

  2014cites this paper
• Bioequivalence: Modeling and Simulation

  2014cites this paper
• Physiologically-based pharmacokinetic modelling and simulation of oral drug bioavailability: Focus on bariatric surgery patients and mechanism-based inhibition of gut wall metabolism

  2014cites this paper
• Model predicting impact of complexation with cyclodextrins on oral absorption

  2013cites this paper
• Dissolution Media for the Analgesic COX II Selective and Biopharmaceutical Classification II Drug- Nimesulide

  2013cites this paper
• Keeping a critical eye on the science and the regulation of oral drug absorption: a review.

  2013cites this paper
• The Preparation and Evaluation of Water-Soluble SKLB610 Nanosuspensions with Improved Bioavailability

  2013cites this paper
• Herstellung fester Dispersionen durch Covermahlung in einer Luftstrahlmühle

  2013cites this paper
• Multilayer Tablets and Their Drug Release Kinetic Models for Oral Controlled Drug Delivery System

  2013cites this paper
• Variability, Uncertainty, and Sensitivity Analysis

  2012cites this paper
• Salt solid dispersions: a formulation strategy to enhance dissolution rate of poorly water-soluble ionic drugs

  2012cites this paper
• Theoretical Framework IV: Gastrointestinal Transit Models and Integration

  2012cites this paper
• Analytical methods for dissolution testing of nanosized drugs

  2012cites this paper
• Selecting the particle size distribution for drugs with low water solubility – mathematical model

  2012cites this paper
• Integrating drug permeability with dissolution profile to develop IVIVC

  2012cites this paper
• Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles.

  2011cites this paper
• An investigation on the correlation between drug dissolution properties and the growth behaviour of granules in high shear mixer

  2011cites this paper
• STUDY OF DIFFERENTIATING ABILITY OF BIORELEVANT MEDIA OVER THE COMPENDIUM MEDIA EXEMPLIFYING WITH EFAVIRENZ AS A MODEL DRUG

  2011cites this paper
• Internal Fines Removal Using Population Balance Model Based Control of Crystal Size Distribution under Dissolution, Growth and Nucleation Mechanisms

  2011cites this paper
• Evaluation of gastrointestinal motility directly from human pharmacokinetic data.

  2011cites this paper
• An update on computational oral absorption simulation

  2011cites this paper
• The developability classification system: application of biopharmaceutics concepts to formulation development.

  2010cites this paper
• Modeling the influence of cyclodextrins on oral absorption of low‐solubility drugs: I. Model development

  2010cites this paper
• Power law IVIVC: an application of fractional kinetics for drug release and absorption.

  2010cites this paper
• Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.

  2010cites this paper
• Kinetic modeling on drug release from controlled drug delivery systems.

  2010cites this paper
• Drug Salts and Solubilization: Modeling the Influence of Cyclodextrins on Oral Absorption

  2010cites this paper
• Dissolution modeling of bead formulations and predictions of bioequivalence for a highly soluble, highly permeable drug.

  2010cites this paper
• Dynamic dissolution: a step closer to predictive dissolution testing?

  2010cites this paper
• Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation

  2010cites this paper
• A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recognition of covariates.

  2009cites this paper
• Mechanistic Approaches to Predicting Oral Drug Absorption

  2009cites this paper
• Introduction to computational oral absorption simulation

  2009cites this paper
• Particle, Powder, and Compact Characterization

  2009cites this paper
• Calculation of fraction of dose absorbed: comparison between analytical solution based on one compartment steady state concentration approximation and dynamic seven compartment model

  2009cites this paper
• Chapter 8 – Particle, Powder, and Compact Characterization

  2009cites this paper
• Understanding the Effect of API Properties on Bioavailability Through Absorption Modeling

  2008cites this paper
• Physiologically Based in Silico Models for the Prediction of Oral Drug Absorption

  2008influential citation
• Towards Quantitative Prediction of Oral Drug Absorption

  2008cites this paper
• Gastrointestinal Dissolution and Absorption of Class II Drugs

  2008cites this paper
• Modelling and simulation in drug absorption processes

  2007cites this paper
• Predictive models for oral drug absorption: from in silico methods to integrated dynamical models

  2007cites this paper
• Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.

  2007cites this paper
• Physiologically Based Pharmacokinetics

  2006cites this paper
• Intestinal permeability and excretion into bile control the arrival of amlodipine into the systemic circulation after oral administration

  2006cites this paper
• In vitro - in vivo correlation: from theory to applications.

  2006cites this paper
• Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.

  2006cites this paper
• Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test

  2006cites this paper
• IV-IVC considerations in the development of immediate-release oral dosage form.

  2005cites this paper
• Orally Administered Drug Products: Dissolution Data Analysis with a View to In Vitro‚ÄìIn Vivo Correlation

  2005cites this paper
• Analytical derivation of time required for dissolution of monodisperse drug particles.

  2004cites this paper
• Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds

  2004cites this paper
• Heterogeneous Tube Model for the Study of Small Intestinal Transit Flow

  2004cites this paper